+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Genetic Testing Market Research Report by Type (Carrier Testing, Diagnostic Testing, and New Born Screening), Technology, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 157 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122723
UP TO OFF until Dec 31st 2022
The United States Genetic Testing Market size was estimated at USD 1,870.75 million in 2021, USD 2,236.99 million in 2022, and is projected to grow at a CAGR 15.83% to reach USD 4,519.28 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Genetic Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Carrier Testing, Diagnostic Testing, New Born Screening, Pharmacogenomics, Preimplantation Testing, Prenatal Testing, and Presymptomatic and Predictive Testing.
  • Based on Technology, the market was studied across Cytogenetics, DNA Sequencing, Gene Expression Profiling, Microarrays, and PCR.
  • Based on Application, the market was studied across Autoimmune Disorders, Cancer, Chronic Diseases, Genetic Disorders, and Neurodegenerative Diseases.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Genetic Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Genetic Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Genetic Testing Market, including Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc, Health Network Laboratories, L.P., Invitae Corporation, Laboratory Corporation of America Holdings, Macrogen, Inc., Myriad Genetics, Inc., OPKO Health, Inc., PerkinElmer Inc., PreventionGenetics LLC, Progenity, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Sanofi S.A., Strand Life Sciences Pvt. Ltd., and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Genetic Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Genetic Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Genetic Testing Market?
4. What is the competitive strategic window for opportunities in the United States Genetic Testing Market?
5. What are the technology trends and regulatory frameworks in the United States Genetic Testing Market?
6. What is the market share of the leading vendors in the United States Genetic Testing Market?
7. What modes and strategic moves are considered suitable for entering the United States Genetic Testing Market?
Frequently Asked Questions about the U.S. Genetic Testing Market

What is the estimated value of the U.S. Genetic Testing Market?

The U.S. Genetic Testing Market was estimated to be valued at $1870.75 Million in 2021.

What is the growth rate of the U.S. Genetic Testing Market?

The growth rate of the U.S. Genetic Testing Market is 15.8%, with an estimated value of $4519.28 Million by 2027.

What is the forecasted size of the U.S. Genetic Testing Market?

The U.S. Genetic Testing Market is estimated to be worth $4519.28 Million by 2027.

Who are the key companies in the U.S. Genetic Testing Market?

Key companies in the U.S. Genetic Testing Market include Agilent Technologies, Inc., Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific SE and La Roche AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in awareness among Americans toward early diagnosis of hereditary diseases such as diabetes and breast cancer
5.1.1.2. Growing presence of advanced healthcare infrastructure in the U.S
5.1.2. Restraints
5.1.2.1. Complications involved in predictive genetic testing and dearth of trained professional
5.1.3. Opportunities
5.1.3.1. Robust research and development in genome-related activities for commercialization of genetic tests
5.1.3.2. Emerging integration of automation in predictive gene testing
5.1.4. Challenges
5.1.4.1. Relatively high cost of testing and lack of reimbursement in U.S. policies
5.2. Cumulative Impact of COVID-19
6. Genetic Testing Market, by Type
6.1. Introduction
6.2. Carrier Testing
6.3. Diagnostic Testing
6.4. New Born Screening
6.5. Pharmacogenomics
6.6. Preimplantation Testing
6.7. Prenatal Testing
6.8. Presymptomatic and Predictive Testing
7. Genetic Testing Market, by Technology
7.1. Introduction
7.2. Cytogenetics
7.3. DNA Sequencing
7.4. Gene Expression Profiling
7.5. Microarrays
7.6. PCR
8. Genetic Testing Market, by Application
8.1. Introduction
8.2. Autoimmune Disorders
8.3. Cancer
8.4. Chronic Diseases
8.5. Genetic Disorders
8.6. Neurodegenerative Diseases
9. California Genetic Testing Market10. Florida Genetic Testing Market11. Illinois Genetic Testing Market12. New York Genetic Testing Market13. Ohio Genetic Testing Market14. Pennsylvania Genetic Testing Market15. Texas Genetic Testing Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Agilent Technologies, Inc.
17.2. Becton, Dickinson and Company
17.3. Bio-Rad Laboratories, Inc.
17.4. Centogene N.V.
17.5. Color Genomics, Inc.
17.6. Coopersurgical, Inc.
17.7. Eurofins Scientific SE
17.8. F. Hoffmann-La Roche AG
17.9. Fulgent Genetics, Inc
17.10. Health Network Laboratories, L.P.
17.11. Invitae Corporation
17.12. Laboratory Corporation of America Holdings
17.13. Macrogen, Inc.
17.14. Myriad Genetics, Inc.
17.15. OPKO Health, Inc.
17.16. PerkinElmer Inc.
17.17. PreventionGenetics LLC
17.18. Progenity, Inc.
17.19. QIAGEN N.V.
17.20. Quest Diagnostics Incorporated
17.21. Sanofi S.A.
17.22. Strand Life Sciences Pvt. Ltd.
17.23. Thermo Fisher Scientific Inc.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES GENETIC TESTING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES GENETIC TESTING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES GENETIC TESTING MARKET DYNAMICS
FIGURE 8. UNITED STATES GENETIC TESTING MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES GENETIC TESTING MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENETIC TESTING MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC AND PREDICTIVE TESTING, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC AND PREDICTIVE TESTING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 26. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 28. UNITED STATES GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, 2019-2027 (USD MILLION)
FIGURE 29. UNITED STATES GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES GENETIC TESTING MARKET SIZE, BY MICROARRAYS, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES GENETIC TESTING MARKET SIZE, BY PCR, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES GENETIC TESTING MARKET SIZE, BY PCR, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2027
FIGURE 41. UNITED STATES GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES GENETIC TESTING MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES GENETIC TESTING MARKET SIZE, BY CANCER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. CALIFORNIA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. FLORIDA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. ILLINOIS GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. NEW YORK GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. OHIO GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. PENNSYLVANIA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. TEXAS GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES GENETIC TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 59. UNITED STATES GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 60. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES GENETIC TESTING MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC AND PREDICTIVE TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES GENETIC TESTING MARKET SIZE, BY PCR, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. CALIFORNIA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. CALIFORNIA GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 27. CALIFORNIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 28. CALIFORNIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 30. FLORIDA GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 31. FLORIDA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 32. FLORIDA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 35. ILLINOIS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 36. ILLINOIS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 37. NEW YORK GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. NEW YORK GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 39. NEW YORK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 40. NEW YORK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 41. OHIO GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. OHIO GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 43. OHIO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 44. OHIO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 45. PENNSYLVANIA GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. PENNSYLVANIA GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 47. PENNSYLVANIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 48. PENNSYLVANIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 49. TEXAS GENETIC TESTING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. TEXAS GENETIC TESTING MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 51. TEXAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 52. TEXAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES GENETIC TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 54. UNITED STATES GENETIC TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 55. UNITED STATES GENETIC TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 56. UNITED STATES GENETIC TESTING MARKET RANKING
TABLE 57. UNITED STATES GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 58. UNITED STATES GENETIC TESTING MARKET MERGER & ACQUISITION
TABLE 59. UNITED STATES GENETIC TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. UNITED STATES GENETIC TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. UNITED STATES GENETIC TESTING MARKET INVESTMENT & FUNDING
TABLE 62. UNITED STATES GENETIC TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 63. UNITED STATES GENETIC TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Centogene N.V.
  • Color Genomics, Inc.
  • Coopersurgical, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc
  • Health Network Laboratories, L.P.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Macrogen, Inc.
  • Myriad Genetics, Inc.
  • OPKO Health, Inc.
  • PerkinElmer Inc.
  • PreventionGenetics LLC
  • Progenity, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Strand Life Sciences Pvt. Ltd.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...